[Fragile histidine triad expression in rhabdomyosarcoma]

Shou-li Wang1, Guang-hua Yang, Hong Bu

  • 1Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

Reduced expression of the fragile histidine triad (FHIT) protein is common in rhabdomyosarcoma (RMS). This finding suggests FHIT may be a new prognostic marker for RMS progression, including metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Context:

  • Rhabdomyosarcoma (RMS) is a pediatric soft tissue sarcoma.
  • The role of the fragile histidine triad (FHIT) tumor suppressor in RMS pathogenesis is not fully understood.

Purpose:

  • To investigate the expression levels of FHIT protein in RMS tissues.
  • To explore the potential mechanisms and prognostic significance of FHIT in RMS.

Summary:

  • Immunohistochemistry revealed significantly reduced FHIT expression in 68.2% of RMS cases compared to 35% in normal skeletal muscle.
  • FHIT expression did not correlate with patient sex, tumor histology, or grade.
  • However, reduced FHIT expression was significantly associated with tumor relapse and metastasis.

Impact:

  • Reduced FHIT expression is implicated in the development and progression of RMS.
  • FHIT may serve as a novel biomarker for predicting RMS prognosis and outcomes.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...